EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry

Jim Baggen, Maarten Jacquemyn, Leentje Persoons, Els Vanstreels, Valerie E Pye, Antoni G Wrobel, Valeria Calvaresi, Stephen R Martin, Chloë Roustan, Nora B Cronin, Eamonn Reading, Hendrik Jan Thibaut und 13 weitere

Cell · 2023-08 · 186 (16) · 3427-3442.e22

DOI: 10.1016/j.cell.2023.06.005 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell, 2023-08. Verfasst von Jim Baggen und 24 weiteren Autor:innen. Beteiligte Einrichtung: KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium. …. Hauptthemen laut MEDLINE: SARS-CoV-2, COVID-19. Die Arbeit wurde bisher 155-mal zitiert (Crossref) und nennt 101 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Medical Research Council, Cancer Research UK, Wellcome Trust.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

SARS-CoV-2COVID-19HumansAngiotensin-Converting Enzyme 2Receptors, VirusVirus InternalizationProtein BindingMembrane ProteinsNerve Tissue Proteins

Stichwörter der Autor:innen

ACE2-independent entrySARS-CoV-2TMEM106BTMEM106B crystal structureantibody neutralizationcoronaviruscryo-EMentry receptor

Substanzen

Angiotensin-Converting Enzyme 2Receptors, VirusTMEM106B protein, humanMembrane ProteinsNerve Tissue Proteins

Autor:innen und Institutionen

  • KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium. Electronic address: jim.baggen@kuleuven.be.
  • KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute, Leuven 3000, Belgium.
  • Chromatin Structure and Mobile DNA Laboratory, Francis Crick Institute, London NW1 1AT, UK.
  • Structural Biology of Disease Processes Laboratory, Francis Crick Institute, London NW1 1AT, UK.
  • Department of Chemistry, Britannia House, 7 Trinity Street, King's College London, London SE1 1DB, UK.
  • Structural Biology Science Technology Platform, Francis Crick Institute, London NW1 1AT, UK.

Förderung

  • Medical Research Council
  • Cancer Research UK
  • Wellcome Trust
  • UK Research and Innovation
  • FWO
  • King's College London
  • Francis Crick Institute

Zitieren

APA

Baggen, J., Jacquemyn, M., Persoons, L., Vanstreels, E., Pye, V. E., Wrobel, A. G., Calvaresi, V., Martin, S. R., Roustan, C., Cronin, N. B., Reading, E., Thibaut, H. J., Vercruysse, T., Maes, P., De Smet, F., Yee, A., Nivitchanyong, T., Roell, M., Franco-Hernandez, N., …, & Daelemans, D. (2023). TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell, 186(16), 3427-3442.e22. https://doi.org/10.1016/j.cell.2023.06.005

Vancouver

Baggen J, Jacquemyn M, Persoons L, Vanstreels E, Pye VE, Wrobel AG, et al. TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry. Cell. 2023;186(16):3427-3442.e22. doi:10.1016/j.cell.2023.06.005

BibTeX
@article{Baggen2023,
  author = {Baggen, Jim and Jacquemyn, Maarten and Persoons, Leentje and Vanstreels, Els and Pye, Valerie E and Wrobel, Antoni G and Calvaresi, Valeria and Martin, Stephen R and Roustan, Chloë and Cronin, Nora B and Reading, Eamonn and Thibaut, Hendrik Jan and Vercruysse, Thomas and Maes, Piet and De Smet, Frederik and Yee, Angie and Nivitchanyong, Toey and Roell, Marina and Franco-Hernandez, Natalia and Rhinn, Herve and Mamchak, Alusha Andre and Ah Young-Chapon, Maxime and Brown, Eric and Cherepanov, Peter and Daelemans, Dirk},
  title = {TMEM106B is a receptor mediating ACE2-independent SARS-CoV-2 cell entry},
  journal = {Cell},
  year = {2023},
  volume = {186},
  number = {16},
  pages = {3427--3442.e22},
  doi = {10.1016/j.cell.2023.06.005}
}
Kostenlos starten →